BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1037 related articles for article (PubMed ID: 32734714)

  • 1. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
    Bouayad A
    Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences and similarities between innate immune evasion strategies of human coronaviruses.
    Hoenigsperger H; Sivarajan R; Sparrer KM
    Curr Opin Microbiol; 2024 Jun; 79():102466. PubMed ID: 38555743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
    Liu P; Hong Y; Yang B; Shrestha P; Sajjad N; Chen JL
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2-specific virulence factors in COVID-19.
    Kumar A; Prasoon P; Kumari C; Pareek V; Faiq MA; Narayan RK; Kulandhasamy M; Kant K
    J Med Virol; 2021 Mar; 93(3):1343-1350. PubMed ID: 33085084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immune sensing of coronavirus and viral evasion strategies.
    Kasuga Y; Zhu B; Jang KJ; Yoo JS
    Exp Mol Med; 2021 May; 53(5):723-736. PubMed ID: 33953325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
    Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.
    Wong NA; Saier MH
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Immune Responses against Coronavirus Infections: Friend or Foe?
    Vafaeinezhad A; Atashzar MR; Baharlou R
    Int Arch Allergy Immunol; 2021; 182(9):863-876. PubMed ID: 33951640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Insights into Severe Acute Respiratory Syndrome Coronavirus 2 Pathobiology: Dissecting the Interplay between Cellular Innate Immunity and Immune Evasion.
    Maciorowski D; Mohama S; Alsawi MA; Ilc DJ; Gupta Y; El Idrissi S; Lodolce JP; Kempaiah P
    Crit Rev Immunol; 2020; 40(6):485-496. PubMed ID: 33900693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
    Noor R
    Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons
    Luo W; Huang L; Wang X; Ma Y; Xiao J; Song X; Liu P; Wang Y; Wang Y; Ren Z
    Int J Med Sci; 2021; 18(12):2561-2569. PubMed ID: 34104087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.
    Oh SJ; Shin OS
    J Microbiol; 2022 Mar; 60(3):290-299. PubMed ID: 35122601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.
    Quarleri J; Delpino MV
    Cytokine Growth Factor Rev; 2021 Apr; 58():55-65. PubMed ID: 33608189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immunity: the first line of defense against SARS-CoV-2.
    Diamond MS; Kanneganti TD
    Nat Immunol; 2022 Feb; 23(2):165-176. PubMed ID: 35105981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Update on Innate Immune Responses during SARS-CoV-2 Infection.
    Zhang Y; Chen S; Jin Y; Ji W; Zhang W; Duan G
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses.
    Cao Y; Xu X; Kitanovski S; Song L; Wang J; Hao P; Hoffmann D
    Front Immunol; 2021; 12():656433. PubMed ID: 34122413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular arms race between host innate antiviral response and emerging human coronaviruses.
    Wong LY; Lui PY; Jin DY
    Virol Sin; 2016 Feb; 31(1):12-23. PubMed ID: 26786772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Antiviral Immune Evasion of SARS-CoV-2.
    Beyer DK; Forero A
    J Mol Biol; 2022 Mar; 434(6):167265. PubMed ID: 34562466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.